Mechanisms of Neuronal Protection against Excitotoxicity, Endoplasmic Reticulum Stress, and Mitochondrial Dysfunction in Stroke and Neurodegenerative Diseases

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Prentice, Howard ^a,b   Modi, Jigar Pravinchandra ^a,b   Wu, Jang Yen ^a,b,c  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b FLORIDA ATLANTIC UNIVERSITY   (United States)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CALCIUM; CELL DEATH; CELL MEMBRANES; NEURONS; NITRIC OXIDE; OXIDANTS; OXYGEN;

APOPTOTIC MECHANISMS; ENDOPLASMIC RETICULUM STRESS; MITOCHONDRIAL DYSFUNCTION; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; N ,N-DIETHYLDITHIOCARBAMATE; N METHYL D ASPARTATE RECEPTOR; NEUROLOGICAL DISORDERS; PHARMACOLOGICAL AGENTS;

NEURODEGENERATIVE DISEASES;

CALCIUM; CASPASE 12; CATALASE; CCAAT ENHANCER BINDING PROTEIN; CYTOCHROME C; DIETHYLDITHIOCARBAMIC ACID METHYL ESTER; GLUTAMATE RECEPTOR; GLUTATHIONE PEROXIDASE 1; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HYPOXIA INDUCIBLE FACTOR 1; INITIATION FACTOR 2ALPHA; MANGANESE SUPEROXIDE DISMUTASE; MEMANTINE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; S METHYL N,N DIETHYLDITHIOCARBAMATE SULFOXIDE; SIRTUIN 1; SUPEROXIDE; TAURINE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; XANTHINE OXIDASE; DIETHYLDITHIOCARBAMIC ACID; NEUROTOXIN; S-METHYL N,N-DIETHYLTHIOLCARBAMATE SULFOXIDE;

APOPTOSIS; BRAIN ISCHEMIA; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM STRESS; EXCITOTOXICITY; ISCHEMIC PRECONDITIONING; MELAS SYNDROME; MITOCHONDRIAL DYSFUNCTION; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PROTEIN MISFOLDING; PROTEIN PHOSPHORYLATION; PROTEIN UNFOLDING; REOXYGENATION; REVIEW; TRANSIENT ISCHEMIC ATTACK; UNFOLDED PROTEIN RESPONSE; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CEREBROVASCULAR ACCIDENT; DRUG EFFECTS; HUMAN; METABOLISM; MITOCHONDRION; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DITIOCARB; ENDOPLASMIC RETICULUM STRESS; HUMANS; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; NEUROTOXINS; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; STROKE;

EID: 84947080447     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/964518     Document Type: Review

References (59)

1. M. R. Hara and S. H. Snyder, "Cell signaling and neuronal death, " Annual Review of Pharmacology and Toxicology, vol. 47, no. 1, pp. 117-141, 2007.
2. A. Y. Abramov and M. R. Duchen, "Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity, " Biochimica et Biophysica Acta, vol. 1777, no. 7-8, pp. 953-964, 2008.
3. A. Y. Abramov, A. Scorziello, and M. R. Duchen, "Tree distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation, " Journal of Neuroscience, vol. 27, no. 5, pp. 1129-1138, 2007.
4. R. M. Adibhatla and J. F. Hatcher, "Lipid oxidation and peroxi-dation in CNS Health and disease: from molecular mechanisms to therapeutic opportunities, " Antioxidants and Redox Signaling, vol. 12, no. 1, pp. 125-169, 2010.
5. M. A. Moskowitz, E. H. Lo, and C. Iadecola, "The science of stroke: mechanisms in search of treatments, " Neuron, vol. 67, no. 2, pp. 181-198, 2010.
6. H. Chen, H. Yoshioka, G. S. Kim et al., "Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection, " Antioxidants & Redox Signaling, vol. 14, no. 8, pp. 1505-1517, 2011.
7. W. Dröge, "Free radicals in the physiological control of cell function, " Physiological Reviews, vol. 82, no. 1, pp. 47-95, 2002.
8. M. Damiano, L. Galvan, N. Déglon, and E. Brouillet, "Mitochondria in Huntington's disease, " Biochimica et Biophysica Acta, vol. 1802, no. 1, pp. 52-61, 2010.
9. T. Alleyne, N. Mohan, J. Joseph, and A. Adogwa, "Unraveling the role of metal ions and low catalytic activity of cytochrome C oxidase in Alzheimer's disease, " Journal of Molecular Neuro-science, vol. 43, no. 3, pp. 284-289, 2011.
10. A. M. Brennan, S. W. Suh, S. J. Won et al., "NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation, " Nature Neuroscience, vol. 12, no. 7, pp. 857-863, 2009.
11. T. I. Lam, A. M. Brennan-Minnella, S. J. Won et al., "Intracellular pH reduction prevents excitotoxic and ischemic neuronal death by inhibiting NADPH oxidase, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 46, pp. E4362-E4368, 2013.
12. J. E. Brenman, D. S. Chao, S. H. Gee et al., "Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and?1-syntrophin mediated by PDZ domains, " Cell, vol. 84, no. 5, pp. 757-767, 1996.
13. T. Nakamura, S. Tu, M. Akhtar, C. Sunico, S.-I. Okamoto, and S. Lipton, "Aberrant Protein S-nitrosylation in neurodegenerative diseases, " Neuron, vol. 78, no. 4, pp. 596-614, 2013.
14. D. S. Bredt, P. M. Hwang, C. E. Glatt, C. Lowenstein, R. R. Reed, and S. H. Snyder, "Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase, " Nature, vol. 351, no. 6329, pp. 714-718, 1991.
15. Z. Gu, M. Kaul, B. Yan et al., "S-nitrosylation of matrix metallo-proteinases: signaling pathway to neuronal cell death, " Science, vol. 297, no. 5584, pp. 1186-1190, 2002.
16. 2+ signals and neuronal death in brain ischemia, " Stroke, vol. 38, no. 2, supplement, pp. 674-676, 2007.
17. Z.-G. Xiong, X.-M. Zhu, X.-P. Chu et al., "Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels, " Cell, vol. 118, no. 6, pp. 687-698, 2004.
18. H. K. Kimelberg, B. A. MacVicar, and H. Sontheimer, "Anion channels in astrocytes: biophysics, pharmacology, and function, " Glia, vol. 54, no. 7, pp. 747-757, 2006.
19. J. M. Simard, T. A. Kent, M. Chen, K. V. Tarasov, and V. Gerzanich, "Brain oedema in focal ischaemia: molecular patho-physiology and theoretical implications, " Lancet Neurology, vol. 6, no. 3, pp. 258-268, 2007.
20. M. M. Aarts and M. Tymianski, "TRPMs and neuronal cell death, " Pfugers Archiv European Journal of Physiology, vol. 451, no. 1, pp. 243-249, 2005.
21. T. Abe, A. Kunz, M. Shimamura, P. Zhou, J. Anrather, and C. Iadecola, "The neuroprotective efect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic, " Journal of Cerebral Blood Flow & Metabolism, vol. 29, no. 1, pp. 66-72, 2009.
22. A.Y.Andreyev, Y.E.Kushnareva, andA.A.Starkov, "Mitochon-drial metabolism of reactive oxygen species, " Biochemistry, vol. 70, no. 2, pp. 200-214, 2005.
23. M. A. Perez-Pinzon, R. A. Stetler, and G. Fiskum, "Novel mitochondrial targets for neuroprotection, " Journal of Cerebral Blood Flow and Metabolism, vol. 32, no. 7, pp. 1362-1376, 2012.
24. G. Ambrosio, I. Tritto, and M. Chiariello, "The role of oxygen free radicals in preconditioning, " Journal of Molecular and Cellular Cardiology, vol. 27, no. 4, pp. 1035-1039, 1995.
25. H. E. de Vries, M. Witte, D. Hondius et al., "Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?" Free Radical Biology and Medicine, vol. 45, no. 10, pp. 1375-1383, 2008.
26. J. W. Kaspar, S. K. Niture, and A. K. Jaiswal, "Antioxidant-induced INrf2 (Keap1) tyrosine 85 phosphorylation controls the nuclear export and degradation of the INrf2-Cul3-Rbx1 complex to allow normal Nrf2 activation and repression, " Journal of Cell Science, vol. 125, no. 4, pp. 1027-1038, 2012.
27. J. W. Tompson, S. V. Narayanan, and M. A. Perez-Pinzon, "Redox signaling pathways involved in neuronal ischemic preconditioning, " Current Neuropharmacology, vol. 10, no. 4, pp. 354-369, 2012.
28. J. Ara, S. Fekete, M. Frank, J. A. Golden, D. Pleasure, and I. Valencia, "Hypoxic-preconditioning induces neuroprotection against hypoxia-ischemia in newborn piglet brain, " Neurobiol-ogy of Disease, vol. 43, no. 2, pp. 473-485, 2011.
29. A. P. Raval, K. R. Dave, and M. A. Pérez-Pinzón, "Resveratrol mimics ischemic preconditioning in the brain, " Journal of Cerebral Blood Flow & Metabolism, vol. 26, no. 9, pp. 1141-1147, 2006.
30. H. Zhang, M. Bosch-Marce, L. A. Shimoda et al., "Mito-chondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia, " The Journal of Biological Chemistry, vol. 283, no. 16, pp. 10892-10903, 2008.
31. H. Yoshida, Y.-Y. Kong, R. Yoshida et al., "Apaf1 is required for mitochondrial pathways of apoptosis and brain development, " Cell, vol. 94, no. 6, pp. 739-750, 1998.
32. V. L. Dawson and T. M. Dawson, "Deadly conversations: nuclear-mitochondrial cross-talk, " Journal of Bioenergetics and Biomembranes, vol. 36, no. 4, pp. 287-294, 2004.
33. W. Paschen and T. Mengesdorf, "Endoplasmic reticulum stress response and neurodegeneration, " Cell Calcium, vol. 38, no. 3-4, pp. 409-415, 2005.
34. H. F. Lodish, N. Kong, and L. Wikström, "Calcium is required for folding of newly made subunits of the asialoglycoprotein receptor within the endoplasmic reticulum, " The Journal of Biological Chemistry, vol. 267, no. 18, pp. 12753-12760, 1992.
35. G. Kuznetsov, M. A. Brostrom, and C. O. Brostrom, "Demonstration of a calcium requirement for secretory protein processing and export. Diferential efects of calcium and dithiothre-itol, " The Journal of Biological Chemistry, vol. 267, no. 6, pp. 3932-3939, 1992.
36. G. Mercado, P. Valdes, and C. Hetz, "An ERcentric view of Parkinson's disease, " Trends in Molecular Medicine, vol. 19, no. 3, pp. 165-175, 2013.
37. A. Azfer, J. Niu, L. M. Rogers, F. M. Adamski, and P. E. Kolat-tukudy, "Activation of endoplasmic reticulum stress response during the development of ischemic heart disease, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 291, no. 3, pp. H1411-H1420, 2006.
38. D. J. DeGracia and H. L. Montie, "Cerebral ischemia and the unfolded protein response, " Journal of Neurochemistry, vol. 91, no. 1, pp. 1-8, 2004.
39. R. Kumar, S. Azam, J. M. Sullivan et al., "Brain ischemia and reperfusion activates the eukaryotic initiation factor 2? kinase, PERK, " Journal of Neurochemistry, vol. 77, no. 5, pp. 1418-1421, 2001.
40. C. Pan, H. Prentice, A. L. Price, and J.-Y. Wu, "Benefcial efect of taurine on hypoxia-and glutamate-induced endoplasmic reticulum stress pathways in primary neuronal culture, " Amino Acids, vol. 43, no. 2, pp. 845-855, 2012.
41. C. Hetz, "The unfolded protein response: controlling cell fate decisions under ER stress and beyond, " Nature Reviews Molecular Cell Biology, vol. 13, no. 2, pp. 89-102, 2012.
42. S. Oyadomari and M. Mori, "Roles of CHOP/GADD153 in endoplasmic reticulum stress, " Cell Death and Diferentiation, vol. 11, no. 4, pp. 381-389, 2004.
43. T. Yoneda, K. Imaizumi, K. Oono et al., "Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress, " Journal of Biological Chemistry, vol. 276, no. 17, pp. 13935-13940, 2001.
44. J. Menzie, C. Pan, H. Prentice, and J.-Y. Wu, "Taurine and central nervous system disorders, " Amino Acids, vol. 46, no. 1, pp. 31-46, 2014.
45. J.-Y. Wu and H. Prentice, "Role of taurine in the central nervous system, " Journal of Biomedical Science, vol. 17, supplement 1, article S1, 2010.
46. H. Wu, Y. Jin, J. Wei, H. Jin, D. Sha, and J.-Y. Wu, "Mode of action of taurine as a neuroprotector, " Brain Research, vol. 1038, no. 2, pp. 123-131, 2005.
47. O. I. Aruoma, B. Halliwell, B. M. Hoey, and J. Butler, "The antioxidant action of taurine, hypotaurine and their metabolic precursors, " Biochemical Journal, vol. 256, no. 1, pp. 251-255, 1988.
48. B. P. S. Vohra and X. Hui, "Taurine protects against carbon tetra-chloride toxicity in the cultured neurons and in vivo, " Archives of Physiology and Biochemistry, vol. 109, no. 1, pp. 90-94, 2001.
49. A. El Idrissi and E. Trenkner, "Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism, " Journal of Neuroscience, vol. 19, no. 21, pp. 9459-9468, 1999.
50. S. W. Schafer, J. Azuma, and M. Mozafari, "Role of antioxidant activity of taurine in diabetes, " Canadian Journal of Physiology and Pharmacology, vol. 87, no. 2, pp. 91-99, 2009.
51. S. W. Schafer, K. Shimada, C. J. Jong, T. Ito, J. Azuma, and K. Takahashi, "Efect of taurine and potential interactions with cafeine on cardiovascular function, " Amino Acids, vol. 46, no. 5, pp. 1147-1157, 2014.
52. N. S. Ningaraj, W. Chen, J. V. Schloss, M. D. Faiman, and J.-Y. Wu, "S-methyl-N, N-diethylthiocarbamate sulfoxide elicits neu-roprotective efect against N-methyl-D-aspartate receptor-mediated neurotoxicity, " Journal of Biomedical Science, vol. 8, no. 1, pp. 104-113, 2001.
53. P. Mohammad-Gharibani, J. Modi, J. Menzie et al., "Mode of action of S-methyl-N, N-diethylthiocarbamate sulfoxide (DETC-MeSO) as a novel therapy for stroke in a rat model, " Molecular Neurobiology, vol. 50, no. 2, pp. 655-672, 2014.
54. Z. Gu, T. Nakamura, and S. A. Lipton, "Redox reactions induced by nitrosative stress mediate protein misfolding and mitochon-drial dysfunction in neurodegenerative diseases, " Molecular Neurobiology, vol. 41, no. 2-3, pp. 55-72, 2010.
55. H.-S. V. Chen, J. W. Pellegrini, S. K. Aggarwal et al., "Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: Terapeutic advantage against NMDA receptor-mediated neurotoxicity, " Journal of Neuroscience, vol. 12, no. 11, pp. 4427-4436, 1992.
56. H.-S. V. Chen, Y. F. Wang, P. V. Rayudu et al., "Neuro-protective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are efective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation, " Neuroscience, vol. 86, no. 4, pp. 1121-1132, 1998.
57. L. Texidó, M. Martin-Satúe, E. Alberdi, C. Solsona, and C. Matute, "Amyloid? peptide oligomers directly activate NMDA receptors, " Cell Calcium, vol. 49, no. 3, pp. 184-190, 2011.
58. W. Danysz and C. G. Parsons, "Alzheimer's disease,?-amyloid, glutamate, NMDA receptors and memantine-searching for the connections, " British Journal of Pharmacology, vol. 167, no. 2, pp. 324-352, 2012.
59. G. M. Alley, J. A. Bailey, D. Chen et al., "Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP/PS1 transgenic mice, " Journal of Neuroscience Research, vol. 88, no. 1, pp. 143-154, 2010.